EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Therapeutic and Inflammation Biomarkers: The Role of Meteorin-Like (Metrnl) and Follistatin-Like 1 (FSTL1) in Inflammatory Diseases

Tsvetelina Velikova iD, Konstantina Bakopoulou iD, Milena Gulinac iD, Evelina Manova iD, Hristo Valkov iD, Dimitrina Miteva iD, Russka Shumnalieva iD

International Journal of Molecular Sciences · 06.10.2025 · 26 (19) · 9711

DOI: 10.3390/ijms26199711 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.10.2025. Verfasst von Tsvetelina Velikova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Sofia University St. Kliment Ohridski, 1 Kozyak Street, 1407 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Follistatin-Related Proteins, Biomarkers, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, Meteorin-like protein (Metrnl/IL-41) and Follistatin-like 1 (FSTL1) have emerged as multifunctional molecules that play roles in immunity, metabolism and tissue remodeling. Although they demonstrate pleiotropic effects, they are promising candidates for biomarkers and possible therapeutic targets. The development of new, disease-specific biomarkers will enable clinicians to more effectively monitor inflammatory activity, more accurately assess disease severity, better predict survival, and select appropriate medical treatments. In this review, we present the role of Meteorin-Like Protein (Metrnl) and Follistatin-like 1 (FSTL1) in inflammation in autoimmune rheumatic diseases, as well as in other autoimmune pathologies, cardiovascular diseases, and metabolic diseases. Metrnl, widely expressed in different tissues and organs, is very important for inflammation, immune responses and metabolic disorders. FSTL1 also shows dynamic changes in its expression through various diseases, including cardiovascular conditions, cancer, asthma, and arthritis. Both proteins participate in multiple important signaling pathways, and understanding their diagnostic and therapeutic potential holds great scientific interest. Their complex nature requires careful evaluation of safety concerns and translation to clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Follistatin-Related ProteinsBiomarkersInflammationHumansAnimalsAutoimmune DiseasesMetabolic DiseasesCardiovascular Diseases

Stichwörter der Autor:innen

FSTL1Metrnlautoimmune rheumatic diseasesbiomarkersgastrointestinal inflammatory diseasesinflammationmetabolic diseases

Substanzen

Follistatin-Related ProteinsBiomarkersFSTL1 protein, human

Autor:innen und Institutionen

  • Medical Faculty, Sofia University St. Kliment Ohridski, 1 Kozyak Street, 1407 Sofia, Bulgaria.
  • Faculty of Medicine, Medical University Sofia, Blvd. 'Akademik Ivan Evstratiev Geshov' 15, 1431 Sofia, Bulgaria.
  • Department of General and Clinical Pathology, Medical University of Plovdiv, Bul. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.
  • Department of Genetics, Faculty of Biology, Sofia University "St. Kliment Ohridski", 8 Dragan Tzankov Str., 1164 Sofia, Bulgaria.
  • Clinic of Gastroenterology, University Hospital "Tsaritsa Yoanna-ISUL", "Byalo More" No. 8, 1527 Sofia, Bulgaria.
  • Department of Gastroenterology, Faculty of Medicine, Medical University of Sofia, Blvd. 'Akademik Ivan Evstratiev Geshov' 15, 1431 Sofia, Bulgaria.

ORCID-Profile: Tsvetelina Velikova, Konstantina Bakopoulou, Milena Gulinac, Evelina Manova, Hristo Valkov, Dimitrina Miteva, Russka Shumnalieva

Förderung

  • the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
  • European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria

Zitieren

APA

Velikova, T., Bakopoulou, K., Gulinac, M., Manova, E., Valkov, H., Miteva, D., & Shumnalieva, R. (2025). Emerging Therapeutic and Inflammation Biomarkers: The Role of Meteorin-Like (Metrnl) and Follistatin-Like 1 (FSTL1) in Inflammatory Diseases. International Journal of Molecular Sciences, 26(19), 9711. https://doi.org/10.3390/ijms26199711

Vancouver

Velikova T, Bakopoulou K, Gulinac M, Manova E, Valkov H, Miteva D, et al. Emerging Therapeutic and Inflammation Biomarkers: The Role of Meteorin-Like (Metrnl) and Follistatin-Like 1 (FSTL1) in Inflammatory Diseases. International Journal of Molecular Sciences. 2025;26(19):9711. doi:10.3390/ijms26199711

BibTeX
@article{Velikova2025,
  author = {Velikova, Tsvetelina and Bakopoulou, Konstantina and Gulinac, Milena and Manova, Evelina and Valkov, Hristo and Miteva, Dimitrina and Shumnalieva, Russka},
  title = {Emerging Therapeutic and Inflammation Biomarkers: The Role of Meteorin-Like (Metrnl) and Follistatin-Like 1 (FSTL1) in Inflammatory Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9711},
  doi = {10.3390/ijms26199711}
}
Kostenlos starten →